Purification of an Endogenous Inhibitor of L-Dopa Decarboxylase Activity from Human Serum

By Vassiliou Alice-Georgia   Vassilacopoulou Dido   Fragoulis Emmanuel  

Neurochemical Research, Vol. 30, Iss. 5, 2005-05 ,pp. : 641-649

Springer Publishing Company

Access to resources Recommend Favorite

Identification and Characterization of a Novel Form of the Human L-Dopa Decarboxylase mRNA

By Vassilacopoulou Dido   Sideris Diamantis C.   Vassiliou Alice G.   Fragoulis Emmanuel G.  

Neurochemical Research, Vol. 29, Iss. 10, 2004-10 ,pp. : 1817-1823

Springer Publishing Company

Access to resources Recommend Favorite

Temporal administration of entacapone with slow release L-dopa: pharmacokinetic profile and clinical outcome

By Brusa L.   Pierantozzi M.   Bassi A.   Fedele E.   Lunardi G.   Giacomini P.   Stanzione P.  

Neurological Sciences, Vol. 25, Iss. 2, 2004-06 ,pp. : 53-56

Springer Publishing Company

Access to resources Recommend Favorite

Increased vulnerability to l-DOPA toxicity in dopaminergic neurons from VMAT2 heterozygote knockout mice

By Kariya Shingo   Takahashi Nobuyuki   Hirano Makito   Ueno Satoshi  

Journal of Molecular Neuroscience, Vol. 27, Iss. 3, 2005-10 ,pp. : 277-280

Humana Press, Inc

Access to resources Recommend Favorite

Progress in Direct Striatal Delivery of l-Dopa via Gene Therapy for Treatment of Parkinson's Disease Using Recombinant Adeno-Associated Viral Vectors

By Mandel R.J.   Rendahl K.G.   Snyder R.O.   Leff S.E.  

Experimental Neurology, Vol. 159, Iss. 1, 1999-09 ,pp. : 47-64

Elsevier

Access to resources Recommend Favorite